This intermediate is used to introduce the boron-containing moiety into the drug’s structure. The compound is a direct intermediate in the synthesis of anti-cancer drug bortezomib (Velcade).
(22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid
| API Name | Bortezomib |
|---|---|
| CAS No | 1169630-40-3 |
| Molecular Formula | C39H66N4O15 |
| Molecular Weight | 831.0 g/mol |
| Synonyms | 18-[[(1S)-1-carboxy-4-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-4-oxobutyl]amino -Show More |
Zoho Contact Form - Pharma Intermediates
"*" indicates required fields
Frequently Asked Questions
This intermediate is used to introduce the boron-containing moiety into the drug's structure. The compound is a direct intermediate in the synthesis of anti-cancer drug bortezomib (Velcade).
The CAS number of (22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid is 1169630-40-3.
The molecular formula of (22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid is C39H66N4O15.
The listed molecular weight of (22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid is 831.0 g/mol.
(22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid is listed as being used in connection with the following API: Bortezomib.
The listed synonym or IUPAC name for (22S)-22-carboxy-1-((2,5-dioxo-1-pyrrolidinyl)oxy)-1,10,19,24-tetraoxo-3,6,12,15-tetraoxa-9,18,23-triazahentetracontan-41-oic acid is 18-[[(1S)-1-carboxy-4-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxoethoxy]ethoxy]ethylamino]-2-oxoethoxy]ethoxy]ethylamino]-4-oxobutyl]amino -Show More.